Bioprinting is a technique of creating 3D cell-laden structures by accurately dispensing biomaterial to form complex synthetic tissue. The printed constructs aim to mimic the native tissue by preserving the cell functionality and viability within the printed structure. The 3D bioprinting system presented in this paper aims to facilitate the process of 3D bioprinting through its ability to control the environmental parameters within an enclosed printing chamber. This design of the bioprinter targets to eliminate the need for a laminar flow hood, by regulating the necessary environmental conditions important for cell survival, especially during long duration prints. A syringe-based extrusion (SBE) deposition method comprising multiple nozzles is integrated into the system. This allows for a wider selection of biomaterials that can be used for the formation of the extracellular matrix (ECM). Tissue constructs composed of alginate-gelatin hydrogels were mixed with fibrinogen and human endothelial cells which were then characterized and compared using two methodologies: casted and bioprinted. Furthermore, vasculature was incorporated in the bioprinted constructs using sacrificial printing. Structural and functional characterization of the constructs were performed by assessing rheological, mechanical properties, and analyzing live-dead assay measurements.

The aims of this study were (1) to identify research publications studying noninvasive electrocardiogram (ECG) monitoring devices, (2) to define and categorize current technology in noninvasive ECG recording, and (3) to discuss desirable noninvasive recording features for personalized syncope evaluation to guide technological advancement and future studies. We performed a systematic review of the literature that assessed noninvasive ECG-monitoring devices, regardless of the reason for monitoring. We performed an Internet search and corresponded with syncope experts and companies to help identify further eligible products. We extracted information about included studies and device features. We found 173 relevant papers. The main reasons for ECG monitoring were atrial fibrillation (n = 45), coronary artery disease (n = 10), syncope (n = 8), palpitations (n = 8), other cardiac diseases (n = 67), and technological aspects of monitoring (n = 35). We identified 198 devices: 5 hospital telemetry devices, 12 patches, 46 event recorders, 70 Holter monitors, 23 external loop recorders, 20 mobile cardiac outpatient telemetries, and 22 multifunctional devices. The features of each device were very heterogeneous. There are a large number of ECG-monitoring devices with different features available in the market. Our findings may help clinicians select the appropriate device for their patients. Since there are only a few published articles analyzing their usefulness in syncope patients, further research might improve their use in this clinical setting.

Cardiovascular assessment and fitness training are often overlooked in physical rehabilitation. Many current rehabilitation exercise devices do not allow for the recording and exportation of variables related to cardiovascular fitness. Therefore, the purpose of this work was to design, prototype, and validate a data logger that measures, records, and exports time, heart rate (HR), and speed data with the commercially available rehabilitation device called the Intelligently Controlled Assistive Rehabilitation Elliptical (ICARE). Validation involved using the data logger device in parallel with devices currently used in research environments for measuring HR (TrueOne 2400 metabolic cart with polar HR monitoring chest strap) and speed (ICARE's console). Ten healthy individuals without known disability impacting walking or ability to use the ICARE, exercised on the ICARE while HR and ICARE speed were measured. It was found that the data logger can be used to accurately measure, record, and export HR (linear regression: P < 0.001; R 2 = 0.892) and speed (linear regression: P < 0.001; R 2 = 0.997) data when used with the ICARE.

Cardiovascular disease (CVD), as the most prevalent human disease, incorporates a broad spectrum of cardiovascular system malfunctions/disorders. While cardiac transplantation is widely acknowledged as the optional treatment for patients suffering from end-stage heart failure (HF), due to its related drawbacks, such as the unavailability of heart donors, alternative treatments, i.e., implanting a ventricular assist device (VAD), it has been extensively utilized in recent years to recover heart function. However, this solution is thought problematic as it fails to satisfactorily provide lifelong support for patients at the end-stage of HF, nor does is solve the problem of their extensive postsurgery complications. In recent years, the huge technological advancements have enabled the manufacturing of a wide variety of reliable VAD devices, which provides a promising avenue for utilizing VAD implantation as the destination therapy (DT) in the future. Along with typical VAD systems, other innovative mechanical devices for cardiac support, as well as cell therapy and bioartificial cardiac tissue, have resulted in researchers proposing a new HF therapy. This paper aims to concisely review the current state of VAD technology, summarize recent advancements, discuss related complications, and argue for the development of the envisioned alternatives of HF therapy.

Interventional catheter ablation treatment is a noninvasive approach for normalizing heart rhythm in patients with arrhythmia. Catheter ablation can be assisted with magnetic resonance imaging (MRI) to provide high-contrast images of the heart vasculature for diagnostic and intraprocedural purposes. Typical MRI images are captured using surface imaging coils that are external to the tissue being imaged. The image quality and the scanning time required for producing an image are directly correlated to the distance between the tissue being imaged and the imaging coil. The objective of this work is to minimize the spatial distance between the target tissue and the imaging coil by placing the imaging coil directly inside the heart using an expandable origami catheter structure. In this study, geometrical analysis is utilized to optimize the size and shape of the origami structure and MRI scans are taken to confirm the MRI compatibility of the structure. The origami expandable mechanism could also be applied to other medical device designs that require expandable structures.

As the connection at the proximal tip plays an important role for sensing guidewires, we compared various sensing guidewires with regard to their proximal connectors. The strengths and weaknesses of each are discussed and recommendations for future development are provided. A literature search limited to the English language for the time period from the 1960s to the 2010s has been performed on the USPTO database, Espacenet, and Web of Science. The results have been categorized on the basis of the connector design. A comprehensive overview and classification of proximal connectors for sensing guidewires used for cardiovascular interventions is presented. The classification is based on both the type of connector (fixed or removable) and the type of connection (physical, wireless, or a combination). Considering the complexity of the currently prototyped and tested connectors, future connector development will necessitate an easy and cost-effective manufacturing process that can ensure safe and robust connections.

A systematic study on the influence of the cell geometry of a cardiovascular stent on its radial compliance and longitudinal strain is presented. Eight stent cell geometries—based on common lattice cells—are compared using finite element analysis. It is found that, for a given strut thickness, the radial compliance depends on the shape of the cell and is intimately connected with the longitudinal strain through effective Poisson’s ratio, which depends on the cell geometry. It is demonstrated experimentally that a hybrid stent containing both positive and negative Poisson’s ratio cell lattice geometries exhibited very low values of longitudinal strain. This study indicates that cell geometries may be tailored to minimize longitudinal stresses imposed by the stent onto the artery wall.